Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Jaehde

Showing results (61-70 of 158) with videos related to

Pageof 16
Sort By:
Electrophoresis|April 21, 2018
Optimized two-dimensional gel electrophoresis in an alkaline pH range improves the identification of intracellular CFDA-cisplatin-protein adducts in ovarian cancer cellsSandra Kotz, Maximilian Kullmann, Ganna V Kalayda, et al.
Journal of Clinical Medicine|July 27, 2022
Prioritisation of Adverse Drug Events Leading to Hospital Admission and Occurring during Hospitalisation: A RAND SurveyAnnette Haerdtlein, Anna Maria Boehmer, Katharina Karsten Dafonte, et al.
Cancers|June 19, 2024
Medication Risks and Their Association with Patient-Reported Outcomes in Inpatients with CancerMaximilian Günther, Markus Schuler, Leopold Hentschel, et al.
Clinical Pharmacology and Therapeutics|March 18, 2025
Drug-Event Pairs as Indicators for the Detection of Adverse Drug Reactions during Hospitalization in Routinely Collected Electronic Data SourcesAnna Maria Wermund, Annette Haerdtlein, Wolfgang Fehrmann, et al.
BMJ Open|July 23, 2013
Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort studyLinda Krolop, Yon-Dschun Ko, Peter Florian Schwindt, et al.
International Journal of Cancer|September 24, 2004
Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistanceAnamaria Brozovic, Gerhard Fritz, Markus Christmann, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2012
Pharmaceutical care for patients with breast and ovarian cancerAndrea Liekweg, Martina Westfeld, Michael Braun, et al.
Cells|May 30, 2020
Cisplatin Protein Binding Partners and Their Relevance for Platinum Drug SensitivitySophie Möltgen, Eleonora Piumatti, Giuseppe M Massafra, et al.
Medizinische Monatsschrift Fur Pharmazeuten|March 25, 2011
[Pharmaceutical care of a patient with acute diabetic foot syndrome]Denise Kaufmann, Katharina Walkenbach, Nele Döhler, et al.
Medizinische Monatsschrift Fur Pharmazeuten|May 1, 2009
[Pharmaceutical care for a multimorbid patient mainly suffering from chronic obstructive pulmonary disease]Stefanie Kraff, Stephanie Frisse, Susanne Ringsdorf, et al.
Pageof 16

Showing results (61-70 of 158) with videos related to

Sort By:
Pageof 16
Electrophoresis|April 21, 2018
Optimized two-dimensional gel electrophoresis in an alkaline pH range improves the identification of intracellular CFDA-cisplatin-protein adducts in ovarian cancer cellsSandra Kotz, Maximilian Kullmann, Ganna V Kalayda, et al.
Journal of Clinical Medicine|July 27, 2022
Prioritisation of Adverse Drug Events Leading to Hospital Admission and Occurring during Hospitalisation: A RAND SurveyAnnette Haerdtlein, Anna Maria Boehmer, Katharina Karsten Dafonte, et al.
Cancers|June 19, 2024
Medication Risks and Their Association with Patient-Reported Outcomes in Inpatients with CancerMaximilian Günther, Markus Schuler, Leopold Hentschel, et al.
Clinical Pharmacology and Therapeutics|March 18, 2025
Drug-Event Pairs as Indicators for the Detection of Adverse Drug Reactions during Hospitalization in Routinely Collected Electronic Data SourcesAnna Maria Wermund, Annette Haerdtlein, Wolfgang Fehrmann, et al.
BMJ Open|July 23, 2013
Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort studyLinda Krolop, Yon-Dschun Ko, Peter Florian Schwindt, et al.
International Journal of Cancer|September 24, 2004
Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistanceAnamaria Brozovic, Gerhard Fritz, Markus Christmann, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2012
Pharmaceutical care for patients with breast and ovarian cancerAndrea Liekweg, Martina Westfeld, Michael Braun, et al.
Cells|May 30, 2020
Cisplatin Protein Binding Partners and Their Relevance for Platinum Drug SensitivitySophie Möltgen, Eleonora Piumatti, Giuseppe M Massafra, et al.
Medizinische Monatsschrift Fur Pharmazeuten|March 25, 2011
[Pharmaceutical care of a patient with acute diabetic foot syndrome]Denise Kaufmann, Katharina Walkenbach, Nele Döhler, et al.
Medizinische Monatsschrift Fur Pharmazeuten|May 1, 2009
[Pharmaceutical care for a multimorbid patient mainly suffering from chronic obstructive pulmonary disease]Stefanie Kraff, Stephanie Frisse, Susanne Ringsdorf, et al.
Pageof 16